All Articles

Drs. David Rimm and Roy Herbst identify the top challenges in the area of biomarker testing as well as solutions to these challenges, including availability of sufficient tissue for a large number of biomarker assays, the time some biomarker tests require for completion, the need for a tight association of test results with clinical outcomes, and the development of companion diagnostics for certain immunotherapies.

IWTI 2018 Video Series

Navigating the CMS 14-Day Rule in Biomarker Testing

By David L Rimm, MD, PhD; Roy S. Herbst, MD, PhD

Interview with the Innovators

Video Library

Drs. David Rimm and Roy Herbst review the problems with the CMS “14-Day Rule” since some of the multigene panel biomarker tests require 21 days or longer to complete.

IWTI 2018 Video Series

Financial Constraints to Molecular Biomarker Testing

By David L Rimm, MD, PhD; Roy S. Herbst, MD, PhD

Interview with the Innovators

Video Library

Drs. David Rimm and Roy Herbst discuss the challenges of reimbursement by payers and the costs to pathology department of molecular biomarker testing, especially immunohistochemistry and DNA testing.

Harnessing Time to Achieve Our Goals

By Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG

Letters from Lillie

December 2018 Vol 9, No 12

As 2018 comes to a close, I marvel at how quickly time passes. Yet, I am simultaneously filled with a sense of pride at how much we have accomplished in this past year.

Efficacy of the Competency-Based Oncology Patient Navigator Training

By Kanako Kashima, MPH; Serena Phillips, RN, MPH, DrPH; Allison Harvey, MPH, CHES; Aubrey Villalobos, MPH, MEd, DrPH(c); Mandi L. Pratt-Chapman, PhD, MA, HON-OPN-CG

Original Research

December 2018 Vol 9, No 12

The authors discuss the efficacy of “The Fundamentals” – a competency-based online Oncology Patient Navigator Training designed by The George Washington University Cancer Center.

Design and Development of a Prostate Cancer Survivor Self-Reported Registry

By Antoine Richards, MPH; Kimberly E Davis, PhD; Reginald O Gooden, MPH, ORISE Fellow

Original Research

December 2018 Vol 9, No 12

The authors explore how minorities affected by prostate cancer can become more informed and active in the decision-making process.

Fighting Compassion Fatigue and Burnout by Building Emotional Resilience

By Emily Gentry, RN, BSN, HON-ONN-CG, OCN

Compassion Fatigue & Burnout

December 2018 Vol 9, No 12

Insights into compassion fatigue, burnout, and the relevance of resilience to oncology navigators.

PACIFIC: Practice-Changing Trial in Stage III Unresectable NSCLC

Conference Correspondent, Highlights From IASLC

December 2018 Vol 9, No 12

The PD-L1 inhibitor durvalumab showed an overall survival benefit in patients with unresectable stage III non–small cell lung cancer (NSCLC) in the phase 3 PACIFIC trial.

Switching on the Light: A Model Immunotherapy Program for Oncology Practices

Highlights From ACCC

December 2018 Vol 9, No 12

Immunotherapy is one of the hottest concepts in oncology care. Also called biologic therapy, this type of cancer treatment boosts the body’s own natural defenses to fight cancers.

Telling Your Story Through Numbers

By Kendra Barber, MHA, RN, OCN; Rachelle Goerke, MSN, BSN, OCN; Rachelle Goerke, MSN, BSN, OCN

Establishing a Successful Navigation Program

December 2018 Vol 9, No 12

As a navigation leader, you may want to start an oncology nurse navigation program, but you may not be sure where to start. Who do you talk to first? What message do you convey?

All Articles

Page 186 of 283

Connect with Us

Subscribe Today!

I'd like to receive:

Please enter your mailing address.